[Federal Register Volume 82, Number 73 (Tuesday, April 18, 2017)]
[Notices]
[Pages 18307-18308]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-07764]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVCES

Substance Abuse and Mental Health Services Administration


Agency Information Collection Activities: Proposed Collection; 
Comment Request

    In compliance with Section 3506(c)(2)(A) of the Paperwork Reduction 
Act of 1995 concerning opportunity for public comment on proposed 
collections of information, the Substance Abuse and Mental Health 
Services Administration (SAMHSA) will publish periodic summaries of 
proposed projects. To request more information on the proposed project 
or to obtain a copy of the information collection plans, call the 
SAMHSA Reports Clearance Officer at (240) 276-1243.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology.

Proposed Project: Strategic Prevention Framework for Prescription Drugs 
(SPF-Rx)--New

    The Substance Abuse and Mental Health Services Administration 
(SAMHSA)'s Center for Substance Abuse Prevention (CSAP) aims to conduct 
a cross-site evaluation of the Strategic Prevention Framework for 
Prescription Drugs (SPF-Rx) program. The SPF-Rx program is designed to 
address nonmedical use of prescription drugs (as well as opioid 
overdoses) by raising awareness about the dangers of sharing 
medications. and by working with pharmaceutical and medical 
communities. The SPF-Rx program aims to promote collaboration between 
states/tribes and pharmaceutical and medical communities to understand 
the risks of overprescribing to youth ages 12-17 and adults 18 years of 
age and older. The program also aims to enhance capacity for, and 
access to, Prescription Drug Monitoring Program (PDMP) data for 
prevention purposes.
    The SPF-Rx program aims to address SAMHSA's priorities on 
prevention and

[[Page 18308]]

reduction of prescription drug and illicit opioid misuse and abuse. Its 
indicators of success are reductions in opioid overdoses and the 
incorporation of PDMP data into needs assessments and strategic plans. 
Data collected through the tools described in this statement will be 
used for the national cross-site evaluation of SAMHSA's SPF-Rx program. 
This package covers continued data collection through 2020, as the 
evaluation is expected to continue through at least that time; however, 
the Program Evaluation for Prevention Contract (PEP-C) is scheduled to 
conduct a national cross-site evaluation of SPF-Rx through September 
2018. The PEP-C team will systematically collect and maintain an Annual 
Implementation Instrument (AII) and outcomes data submitted by SPF-Rx 
grantees through the online PEP-C Management Reporting Tool (MRT).
    SAMHSA is requesting approval for data collection for the SPF-Rx 
cross-site evaluation with the following four instruments:
     Grantee Interview to obtain the perspective of the 
implementing Project Directors (PDs) or their staff on important 
topics, including infrastructure and capacity, collaboration, 
leveraging funding and resources, criteria and use of evidence-informed 
interventions, monitoring and evaluation, collaboration, challenges, 
and health disparities. Information from these interviews will help 
inform SPF-Rx cross-site evaluation reports and will help identify 
lessons learned and success stories from grantees' SPF-Rx programs.
     Grantee- and Community-Level Outcomes Modules to collect 
data on key SPF-Rx program outcomes, including opioid misuse and abuse, 
opioid overdoses, and opioid prescribing patterns. Grantees will 
provide outcomes data at the grantee level for their state, tribal 
area, or jurisdiction, as well as at the community level for each of 
their subrecipient communities.
     Substitute Data Source Request to allow grantees to 
request permission from SAMHSA to use ``substitute measures'' for their 
outcomes data--that is, measures that differ from a list of preapproved 
outcomes measures.
     Annual Implementation Instrument to collect data completed 
by grantees and subrecipient community PDs. Data collected from the 
survey will be used to monitor subrecipient and state, tribal entity, 
or jurisdiction performance, and to evaluate the effectiveness of the 
SPF-Rx program across states, tribal entities, and jurisdictions.
     Grantee Interview to collect semistructured telephone 
interview data to gather more in-depth information on organizational 
infrastructure, use of PDMP data.
     Evaluation Plan to allow grantees to outline their local 
evaluation plan. This section should include goals and objectives, 
performance measures, a data analysis plan, and reporting plan.

                                        Annualized Data Collection Burden
----------------------------------------------------------------------------------------------------------------
                                     Number of     Responses per   Total number      Hours per     Total burden
           Instrument               respondents     respondent     of responses      response          hours
----------------------------------------------------------------------------------------------------------------
Grantee-Level Outcomes Module...              25               1              25               3              75
Community-Level Outcomes Module.              25               1              25               3              75
Substitute Data Request Form....            3.67               1            3.67               1            3.67
Annual Implementation Instrument             100               1             100             2.3             230
Grantee-Level Interview.........              17               1              17             1.5            25.5
Evaluation Plan.................              25               1              25               8             200
    Overall Total...............          170.67  ..............          170.67  ..............          609.17
----------------------------------------------------------------------------------------------------------------
Note: Annualized Data Collection Burden captures the average number of respondents and responses, burden hours,
  and respondent cost over the 3 years (FY2018-FY2020).

    Send comments to Summer King, SAMHSA Reports Clearance Officer, 
5600 Fishers Lane, Room 15E57-B, Rockville, Maryland 20857, OR email a 
copy to [email protected]. Written comments should be received 
by June 19, 2017.

Summer King,
Statistician.
[FR Doc. 2017-07764 Filed 4-17-17; 8:45 am]
 BILLING CODE 4162-20-P